AZD5438 in Patients with Advanced Solid Malignancies
Study identifier:D0110C00005
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients with Advanced Solid Malignancies
Medical condition
Neoplasms
Phase
Phase 1
Healthy volunteers
No
Study drug
AZD5438
Sex
All
Actual Enrollment
-
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Jul 2004
Primary Completion Date: 01 Dec 2005
Study Completion Date: 01 Dec 2005
Study design
Allocation: None
Endpoint Classification: None
Intervention Model: None
Masking: None
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
